1
TÍTULO: A phase i dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer  Full Text
AUTORES: Coombes, RC; Cardoso, F; Isambert, N; Lesimple, T; Soulie, P; Peraire, C; Fohanno, V; Kornowski, A; Ali, T; Schmid, P;
PUBLICAÇÃO: 2013, FONTE: Breast Cancer Research and Treatment, VOLUME: 140, NÚMERO: 1
INDEXADO EM: Scopus CrossRef